Defeating Cancer:

The Challenge.

Our Mission.

In the past three decades, tremendous progress has been made in the fight against cancer, but there is still so much more work to be done. At Deciphera we remain steadfast in our mission to improve the lives of people living with cancer - and that passion for making a difference extends to the patient groups and communities in which we live and work.

deciphera-ron-ver2

Our Pipeline

Enabled by our proprietary kinase switch control inhibitor platform, we have built a diverse pipeline of wholly-owned, orally administered drug candidates that includes 3 clinical-stage and 2 research-stage programs.

View Our Pipeline »

Latest News & Events

September 05, 2019
Deciphera Pharmaceuticals Announces Late-Breaking Oral Presentation of Pivotal Phase 3 INVICTUS Data at the European Society for Medical Oncology (ESMO) 2019 Congress »
September 03, 2019
Deciphera Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock »
August 19, 2019
Deciphera Pharmaceuticals Announces Closing of Public Offering of Common Stock »

Ron’s Story

“There have been a lot of ups and downs of my journey and sometimes I get a little frightened but through it all I’ve tried to stay positive. To be honest, it’s difficult sometimes but I feel the longer I fight, the more opportunity there is for future medical solutions. My goal is to hang around long enough so that when researchers are successful, I’m successful. Hope is, and always will be, the magic ingredient… Keep hope alive.” Watch his story

Make a Difference

MAKING A DIFFERENCE

At Deciphera we place a premium on being innovative and creative in our approach and relentless in our efforts to help patients live longer and healthier lives. We strive to combine great science, focus, and collaboration and an exciting, fun and energizing work environment.

Learn More About Our Workplace »

View Our Job Openings »